CRP and depressive symptom measurement: Most notably, statins have demonstrated diverse immunomodulatory and anti-inflammatory effects (both dependent and independent of their lipid-lowering activity), such as downregulation of C-reactive protein (CRP), interleukins and tumour necrosis factor (TNF), many of which have been implicated in depression risk [14].